IL 3581 (Theophylline extended release 300 mg)

Pill imprint IL 3581 has been identified as Theophylline extended release 300 mg.

Theophylline is used in the treatment of asthma, acute; apnea of prematurity; asthma, maintenance and belongs to the drug class methylxanthines. Risk cannot be ruled out during pregnancy. Theophylline 300 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for IL 3581 (Theophylline extended release 300 mg)

Theophylline extended release 300 mg IL 3581
Theophylline extended release 300 mg IL 3581
Theophylline extended release
IL 3581
300 mg
Prescription only
Drug Class:
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Inwood Laboratories Inc.
National Drug Code (NDC):
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
00182-1400 Goldline Laboratories Inc
00677-0817 URL Pharma, Inc.(now Sun Pharma)
00904-1612 Major Pharmaceuticals
00456-4330 Forest Pharmaceuticals, Inc
00603-5946 Qualitest Pharmaceuticals
54569-2483 A S Medication Solutions LLC (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)